SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-21-052533
Filing Date
2021-04-20
Accepted
2021-04-20 16:16:16
Documents
6
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm212620d1_pre14a.htm PRE 14A 294824
2 GRAPHIC tm212620d1_pre14aimg001.jpg GRAPHIC 13981
3 GRAPHIC tm212620d1_pre14aimg002.jpg GRAPHIC 1790
4 GRAPHIC tm212620d1_pre14aimg003.jpg GRAPHIC 1747
5 GRAPHIC image_002.jpg GRAPHIC 105501
6 GRAPHIC image_003.jpg GRAPHIC 141343
  Complete submission text file 0001104659-21-052533.txt   660644
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38128 | Film No.: 21838029
SIC: 2834 Pharmaceutical Preparations